Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
Evil Rabbit's Profile
Displaying 2951-3000 of 6046 result(s).
CYDY CytoDyn Inc
07/28/2021 2:07:48 PM
My theory is that 5%er is MDV back (7)
CYDY CytoDyn Inc
07/28/2021 11:12:08 AM
There are no 13D official represen (3)
CYDY CytoDyn Inc
07/28/2021 11:10:20 AM
5%er I disagree with deleting all y (4)
CYDY CytoDyn Inc
07/28/2021 11:02:02 AM
Are you MDV by any chance? He stopp (6)
CYDY CytoDyn Inc
07/28/2021 1:23:41 AM
Oh was RTB deleted again? Wasn’t (3)
CYDY CytoDyn Inc
07/28/2021 12:35:53 AM
There IS a board the doesn’t del (1)
CYDY CytoDyn Inc
07/27/2021 4:36:17 PM
I did but now I’m waiting.
CYDY CytoDyn Inc
07/27/2021 3:22:09 PM
Am I the only one not adding due to (2)
CYDY CytoDyn Inc
07/27/2021 3:03:09 PM
Does anyone know when the next buyi (11)
CYDY CytoDyn Inc
07/27/2021 1:53:21 PM
Shareholders obviously do not trust (12)
CYDY CytoDyn Inc
07/27/2021 1:40:55 PM
FWIW, I haven't deleted the 13D pos (2)
CYDY CytoDyn Inc
07/27/2021 1:34:05 PM
Why do people expect a plan to be u (11)
CYDY CytoDyn Inc
07/27/2021 1:13:31 PM
I should delete these answers just (8)
CYDY CytoDyn Inc
07/27/2021 11:07:52 AM
That’s why I said a month ago, h (13)
CYDY CytoDyn Inc
07/26/2021 9:45:23 PM
“Take back?” Ohm already posted (5)
CYDY CytoDyn Inc
07/26/2021 8:24:39 PM
Welcome back. Agree with every word (3)
CYDY CytoDyn Inc
07/26/2021 8:04:49 PM
I’ve had the same theory for a lo (7)
CYDY CytoDyn Inc
07/26/2021 6:21:19 PM
The main 13D argument seems to be t (14)
CYDY CytoDyn Inc
07/26/2021 5:46:55 PM
Did any model correctly predict Cov (9)
CYDY CytoDyn Inc
07/26/2021 4:55:39 PM
Most models and media folk have ove (4)
CYDY CytoDyn Inc
07/26/2021 4:46:11 PM
I do have to wonder if Dr. Yo got a (4)
CYDY CytoDyn Inc
07/26/2021 4:23:53 PM
There'll be a lot of crow to eat wh (4)
CYDY CytoDyn Inc
07/26/2021 4:21:47 PM
Spot on assessment in the Emerging (7)
CYDY CytoDyn Inc
07/26/2021 4:19:58 PM
Yo did say it all. I saw the Tweets (11)
CYDY CytoDyn Inc
07/26/2021 4:14:32 PM
the market certainly is not thrille (6)
CYDY CytoDyn Inc
07/26/2021 4:11:58 PM
Aren't you the guy who admitted you (15)
CYDY CytoDyn Inc
07/26/2021 4:07:56 PM
Dr. Yo used to say Leronlimab was t (18)
CYDY CytoDyn Inc
07/26/2021 3:27:41 PM
While the drop from say $9 to $5 mi (14)
CYDY CytoDyn Inc
07/26/2021 12:27:28 AM
in a raging pandemic, even those r (14)
CYDY CytoDyn Inc
07/26/2021 12:02:02 AM
Dr. Yo and another doctor said the (5)
CYDY CytoDyn Inc
07/25/2021 7:21:08 PM
Of course they delete it within min (4)
CYDY CytoDyn Inc
07/25/2021 2:45:54 PM
we wouldn't need you That is the 13 (7)
CYDY CytoDyn Inc
07/25/2021 12:19:58 PM
You might if its clear (to many) t (8)
CYDY CytoDyn Inc
07/25/2021 11:46:39 AM
i'm wondering if a PR about inject (9)
CYDY CytoDyn Inc
07/25/2021 11:38:23 AM
Because if you own a piece of Incel (6)
CYDY CytoDyn Inc
07/24/2021 9:32:12 PM
Yup, critics can knock Nader for so (15)
CYDY CytoDyn Inc
07/24/2021 8:16:04 PM
I’d rather keep a Mgmt team with (19)
CYDY CytoDyn Inc
07/24/2021 3:22:21 AM
I love this part about the Covid tr (10)
CYDY CytoDyn Inc
07/23/2021 8:00:25 PM
I could not believe it was posted
CYDY CytoDyn Inc
07/23/2021 6:27:57 PM
Fellow Mods, if Rubraquercus ever p (16)
CYDY CytoDyn Inc
07/23/2021 2:54:16 PM
The clinical trial process (includi (26)
CYDY CytoDyn Inc
07/23/2021 2:49:14 PM
Was surprised that I was able to bu (2)
CYDY CytoDyn Inc
07/23/2021 2:24:33 PM
Is this who we are? Semi-childish? (4)
CYDY CytoDyn Inc
07/23/2021 1:13:25 PM
I haven't deleted any of your publi
CYDY CytoDyn Inc
07/23/2021 12:48:28 PM
Anyone else getting PMs from the in (30)
CYDY CytoDyn Inc
07/23/2021 12:45:09 AM
Scott Kelly mentioned that no compa (14)
CYDY CytoDyn Inc
07/23/2021 12:16:56 AM
Crap like this certainly doesn’t (6)
CYDY CytoDyn Inc
07/22/2021 11:20:34 PM
You bash. It’s extra insulting wh
CYDY CytoDyn Inc
07/22/2021 10:48:49 PM
Dude, take your soft bashing elsewh (10)
CYDY CytoDyn Inc
07/22/2021 7:49:03 PM
I find it ironic that the FDA doesn (13)
Go to page:
  • << First
  • < Previous
  • 59
  • 60
  • Next >

Recent Articles

  • Eli Lilly and Co. Faces Legal Setback in Drug Pricing Case
  • Celebrating Remarkable Healthcare Leaders in Social Health Awards
  • A Deep Dive into D.C. Autonomy with Senator Jain & Councilmember
  • A New Era Begins: EMCC USA Launches to Transform Coaching
  • Synopsys, Inc. Faces Turbulence After Major Financial Setback
  • Quantum Corporation Investors Urged to Act Ahead of Key Deadline
  • Nucor and Reliance: Resilient Players in Steel Market Dynamics
  • Join the Nutex Health Inc. Class Action for Investor Recovery
  • Innovative Collaboration: Plug and Play Partners with Ricoh
  • Understanding Apple's Current Price-to-Earnings Dynamics
  • Understanding Bearish Trends of Major Investors on UPS Options
  • Exploring Recent Trends in Options Trading for Serve Robotics
  • Navigating AutoZone's Investment Landscape: Insights and Trends
  • Sable Offshore Faces Legal Action for Investor Misleading Claims
  • ImageTrend Sets New Standards with Compliance Achievement
  • Plug and Play and Ricoh Collaborate for Workplace Innovation
  • Elderly Investors Seek Justice After Fund Collapse by Stifel
  • UNice Hair Launches Innovative Bye-Bye Slip™ Wig for Comfort
  • Investors Invited to Join the SelectQuote Class Action Today
  • APT212 Forms Strategic Alliance with Compass for Growth
  • Investing in Small-Cap Stocks After Federal Rate Cuts
  • Resbiotic Nutrition Inc. Secures $14.5M for Growth in Health
  • Octopus Titan VCT Shares Insights on Investment Policy Change
  • Westchester Medical Center Welcomes New Chief Clinical Officer
  • Ashley Graham Partners with Breescape to Transform Sleep Comfort
  • Innovative AI Platform Launches to Transform Content Creation
  • APT212 and Compass Join Forces to Transform Real Estate
  • Gistvox: Revolutionizing Storytelling Through Voice
  • Urgent Call for Sable Offshore Corp. Investors to Act Now
  • LifeMD, Inc. Securities Class Action: How to Join the Fight
  • Evaluating TeraWulf's Market Position and Short Interest Trends
  • Understanding the Decrease in Otis Worldwide's Short Interest
  • Analyzing Core Scientific's Short Interest and Market Trends
  • Thermacell Repellents Named Among Top Workplaces for 2025
  • Experience the Silence: Slotozilla's New Interactive Project
  • Unlocking Leadership: A Guide for First-Time Supervisors
  • Maximizing Efficiency: Dan Herbatschek on Inventory Management
  • Celebrating Artistic Heritage with Tequila Don Julio 70 Masterpiece
  • Analyzing Enbridge's Price-to-Earnings Ratio's Impact on Investors
  • Market Fluctuations: Insights into Recent Stock Movements
  • Discover Growatt's Groundbreaking Solar Innovations for Homes
  • Jackery Unleashes New HomePower Solutions at Industry Event
  • Exciting Details on the 10th Anniversary RISE Festival Schedule
  • Class Action Alert: Legal Opportunities for AI, LFMD, SMLR, DOW Investors
  • Neogen Corporation Faces Legal Stakes Following Share Price Drop
  • Investor Alert: RxSight, Inc. Faces Securities Fraud Scrutiny
  • Investors of Fiserv, Inc. (FI) Pursue Action Amid Stock Decline
  • Shell's Strategic Share Buy-Back Initiative Updates
  • Middlesex Water Company CEOs Share Insights at Upcoming Event
  • Understanding the Voting Rights and Capital of Nanobiotix
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site